Terms: = Colorectal cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
998 results:
1. Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications.
Tong X; Qiao S; Dong Z; Zhao X; Du X; Niu W
J Nanobiotechnology; 2024 Jul; 22(1):409. PubMed ID: 38992688
[TBL] [Abstract] [Full Text] [Related]
2. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer.
Bajpai P; Agarwal S; Afaq F; Al Diffalha S; Chandrashekar DS; Kim HG; Shelton A; Miller CR; Singh SK; Singh R; Varambally S; Nagaraju GP; Manne A; Paluri R; Khushman M; Manne U
J Exp Clin Cancer Res; 2024 Jul; 43(1):192. PubMed ID: 38992681
[TBL] [Abstract] [Full Text] [Related]
3. Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and stat3 signaling regardless of KRAS or BRAF mutational status.
Zhang J; Zhou L; Zhao S; El-Deiry WS
Oncotarget; 2024 Jul; 15():424-438. PubMed ID: 38953895
[TBL] [Abstract] [Full Text] [Related]
4. Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting stat3.
Fan D; Liu P; Li Z; He X; Zhang L; Jiang W; Ang W; Yang T
Bioorg Chem; 2024 Sep; 150():107565. PubMed ID: 38905884
[TBL] [Abstract] [Full Text] [Related]
5. Interleukin-6 serves as a critical factor in various cancer progression and therapy.
Mohamed AH; Ahmed AT; Al Abdulmonem W; Bokov DO; Shafie A; Al-Hetty HRAK; Hsu CY; Alissa M; Nazir S; Jamali MC; Mudhafar M
Med Oncol; 2024 Jun; 41(7):182. PubMed ID: 38900329
[TBL] [Abstract] [Full Text] [Related]
6. Structural Optimization of Marine Natural Product Pretrichodermamide B for the Treatment of Colon cancer by Targeting the JAK/stat3 Signaling Pathway.
Zhou Y; He N; Liu Q; Li R; Yang L; Kang W; Zhang X; Xu X; Yao G; Wang P; Wang CY; Yang J; Liu Z
J Med Chem; 2024 Jul; 67(13):10783-10794. PubMed ID: 38888591
[TBL] [Abstract] [Full Text] [Related]
7. CLK3 positively promoted colorectal cancer proliferation by activating IL-6/stat3 signaling.
Ma Y; Gao F; Liu Y
Exp Cell Res; 2024 Jul; 440(1):114132. PubMed ID: 38885806
[TBL] [Abstract] [Full Text] [Related]
8. The Glabridin from Huangqin Decoction Prevents the Development of Ulcerative Colitis into Colitis-Associated colorectal cancer by Modulating MMP1/MMP3 Activity.
Li R; Chi H; Liao X; Cen S; Zou Y
Int Immunopharmacol; 2024 Jun; 135():112262. PubMed ID: 38805906
[TBL] [Abstract] [Full Text] [Related]
9. Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis.
Ma Z; Sun Y; Yu Y; Xiao W; Xiao Z; Zhong T; Xiang X; Li Z
Cell Commun Signal; 2024 May; 22(1):295. PubMed ID: 38802814
[TBL] [Abstract] [Full Text] [Related]
10. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/stat3 axis in a colorectal cancer model.
Sun Z; Xu Y; Shao B; Dang P; Hu S; Sun H; Chen C; Wang C; Liu J; Liu Y; Hu J
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782541
[TBL] [Abstract] [Full Text] [Related]
11. PDIA3 driven stat3/PD-1 signaling promotes M2 TAM polarization and aggravates colorectal cancer progression.
Fan J; Wang L; Zhang C; Wu X; Han L; Zhang X; Gao S; Xue J; Zhang Q
Aging (Albany NY); 2024 May; 16(10):8880-8897. PubMed ID: 38761176
[TBL] [Abstract] [Full Text] [Related]
12. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
Zeng T; Ling C; Liang Y
Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
Stany B; Mishra S; Rao KVB
Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
[TBL] [Abstract] [Full Text] [Related]
14. Vesicle-associated membrane protein 8 knockdown exerts anti-proliferative, pro-apoptotic, anti-autophagic, and pro-ferroptotic effects on colorectal cancer cells by inhibition of the JAK/stat3 pathway.
Xu Y; Yang T; Xu Q; Tang Y; Yang Q
J Bioenerg Biomembr; 2024 Aug; 56(4):419-431. PubMed ID: 38720136
[TBL] [Abstract] [Full Text] [Related]
15. Differential expression of angiogenesis-related genes 'VEGF' and 'angiopoietin-1' in metastatic and EMAST-positive colorectal cancer patients.
Torshizi Esfahani A; Mohammadpour S; Jalali P; Yaghoobi A; Karimpour R; Torkamani S; Pardakhtchi A; Salehi Z; Nazemalhosseini-Mojarad E
Sci Rep; 2024 May; 14(1):10539. PubMed ID: 38719941
[TBL] [Abstract] [Full Text] [Related]
16. [Upregulating KLF11 ameliorates intestinal inflammation in mice with 2, 4, 6-trinitrobenesulfonic acid-induced colitis by inhibiting the JAK2/stat3 signaling pathway].
Xi J; Zhang M; Zhang Y; Zhang C; Zhang Y; Wang R; Shen L; Li J; Song X
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):765-772. PubMed ID: 38708511
[TBL] [Abstract] [Full Text] [Related]
17. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting stat3 and elevating ROS level.
Zhang L; Liu P; Jiang Y; Fan D; He X; Zhang J; Luo B; Sui J; Luo Y; Fu X; Yang T
Eur J Med Chem; 2024 Jun; 272():116448. PubMed ID: 38704936
[TBL] [Abstract] [Full Text] [Related]
18. Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2/stat3/GPX4 axis.
Lai JQ; Zhao LL; Hong C; Zou QM; Su JX; Li SJ; Zhou XF; Li ZS; Deng B; Cao J; Qi Q
Acta Pharmacol Sin; 2024 Aug; 45(8):1715-1726. PubMed ID: 38684798
[TBL] [Abstract] [Full Text] [Related]
19. RAC1
Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
[TBL] [Abstract] [Full Text] [Related]
20. Upregulation of EMR1 (ADGRE1) by Tumor-Associated Macrophages Promotes Colon cancer Progression by Activating the JAK2/STAT1,3 Signaling Pathway in Tumor Cells.
Akter R; Park R; Lee SK; Han EJ; Park KS; Park J; Cho MY
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673975
[TBL] [Abstract] [Full Text] [Related]
[Next]
